INSULIN-LIKE GROWTH-FACTOR (IGF)-I AND IGF-II AND IGF-BINDING PROTEIN-1, PROTEIN-2, AND PROTEIN-3 IN CHILDREN AND ADOLESCENTS WITH DIABETES-MELLITUS - CORRELATION WITH METABOLIC CONTROL AND HEIGHT ATTAINMENT

The putative effects of diabetes and metabolic control on circulating levels of insulin-like growth factors (IGFs) and their binding protein s (IGFBPs) remain controversial. In the present study, serum levels of IGF-I and IGF-II and IGFBP-1, -2, and -3 were measured in 58 patients (age, 0.8-17 yr) with treated (51 subjects) or untreated (7 subjects) insulin-dependent diabetes mellitus (IDDM) and were compared with the levels in normal subjects. In the untreated patients IGF-I and IGF-II were decreased as compared with the healthy controls. In the treated diabetics IGF-I and IGF-II were reduced; IGFBP-2 (only in prepubertal subjects) and IGFBP-3 were increased. Furthermore, age-adjusted values of IGF-I, IGF-II, and IGFBP-3 were lower in prepubertal than in puber tal patients. Regression analysis revealed a negative correlation betw een hemoglobin (Hb)A1c and standard deviation scores (SDS) of IGF-I an d a positive association between HbA1c and IGFBP-1 SDS or IGFBP-2 SDS. In the treated patients HbA1ec was positively related to IGFBP-1 SDS and IGFBP-2 SDS when applying simple regression analysis and to IGFBP- 2 SDS when using a multiple regression model. Strong correlations were observed between height SDS and IGF-T SDS, TGF-II SDS, and IGFBP-3 SD S in prepubertal subjects who had had IDDM for at least 2 yr, but not in adolescents. Such correlations have also been found in healthy chil dren and adolescents. In conclusion; 1) IDDM is associated with altera tions of the IGF-IGFBP system, which are partially accounted for by di fferences in metabolic control and pubertal status; 2) the lower plasm a concentrations of serum IGF-I may play a role in the pathogenesis of growth impairment of poorly controlled prepubertal, but not pubertal, children and adolescents with IDDM; and 3) in addition, a potential r ole of the altered IGF-IGFBP system for the development of diabetic la te complications is hypothesized.